Quick Answer
Nutex Health Inc. reported Diluted EPS of $10.48 per share for fiscal year 2025.
Nutex Health Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $10.48 | +8.2% |
| 2024 | $9.69 | +193.3% |
| 2023 | -$10.39 | +89.6% |
| 2022 | -$100.36 | -45718.2% |
| 2021 | $0.22 | +22.2% |
| 2020 | $0.18 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.76 | +551.2% | +363.1% |
| June 30, 2025 | -$2.95 | -4114.3% | -215.2% |
| March 31, 2025 | $2.56 | +3300.0% | +248.8% |
| September 30, 2024 | -$1.72 | -37.6% | -2357.1% |
| June 30, 2024 | -$0.07 | +91.1% | +12.5% |
| March 31, 2024 | -$0.08 | +33.3% | +93.6% |
| September 30, 2023 | -$1.25 | -101.6% | -58.2% |
| June 30, 2023 | -$0.79 | -2533.3% | -558.3% |
- Nutex Health Inc. showed an increase of +8.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Nutex Health Inc.’s diluted eps has grown by 5722.2% (from $0.18 per share to $10.48 per share).
- The most recent figure is from Nutex Health Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: